Publications
Publié le 03/03/2023 -
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort
Auteurs: Collet L, Eberst L, Ludovic G, Debled M, Hrab L, Mouret-Reynier MA, Desmoulins I, Goncalves A, Campone M, Ferrero JM, Brain E, Uwer L, Eymard JC, Dieras V, Simon G, Leheurteur M, Dalenc F, Vanlemmens L, Darlix A, Arnedos M, Bachelot T
Journal: Breast Cancer
En savoir plusPublié le 01/03/2023 - Gastroentérologie et technologies pour la santé
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma: the PRODIGE 41-BEVANEC randomised phase II study
Auteurs: Walter T, Lièvre A, Coriat A, Malka D, Elhajbi F, Di Fiore F, Hentic O, Smith D, Hautefeuille V, Roquin G, Perrier M, Dahan L, Granger V, Sobhani I, Mineur L, Niccoli P, Assenat E, Scoazec JY, Le Malicot K, Lepage C, Lombard-Bohas C
Journal: Lancet Oncol.
En savoir plusPublié le 01/03/2023 - Gastroentérologie et technologies pour la santé
From netrin-1-targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors
Auteurs: David Kryza D*, Wischhusen J*, Richaud M*, Hervieu M, Sidi Boumedine J, Delcros JG, Besse S, Baudier T, Laval PA, Breusa S, Boutault E, Clermidy H, Rama N, Ducarouge B, Chezal JM, Giraudet AL, Walter T, Mehlen P, Sarrut D and Gibert B
Journal: EMBO Molecular Medicine
En savoir plusPublié le 28/02/2023 - Apoptose, cancer et développement
Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancer
Auteurs: Brahim S, Negulescu AM, Geneste C, Schott T, Lin S, Morel LO, Rama N, Gadot N, Treilleux I, Mehlen P, Meurette O.
Journal: Cell, Death & Disease
En savoir plusPublié le 17/02/2023 -
Galectin functions in cancer-associated inflammation and thrombosis
Auteurs: Kruk L, Braun A, Cosset E, Gudermann T, Mammadova-Bach E
Journal: Front Cardiovasc Med
En savoir plusPublié le 15/02/2023 - Immunosurveillance du cancer et ciblage thérapeutique
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
Auteurs: Baulu E, Gardet C, Chuvin N, Depil S
Journal: Science Advances
En savoir plus